All News Shattuck Labs, Inc.

Equities

STTK

US82024L1035

Market Closed - Nasdaq Other stock markets 21:00:00 09/05/2024 BST			5-day change	1st Jan Change
10.66 ^USD	+1.62%		-3.96%	+49.51%

05-02	Shattuck Labs, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-04	Shattuck Labs, Inc. Announces Board Appointments	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Shattuck Labs : May 02, 2023 Shattuck Labs Corporate Presentation	05-02	PU
Shattuck Labs, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-02	CI
Shattuck Labs Reports First Quarter 2024 Financial Results and Recent Business Highlights	05-02	GL
Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024	04-09	GL
Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare Conference	04-01	GL
Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of Directors	03-04	GL
Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of Directors	03-04	AQ
Shattuck Labs, Inc. Announces Board Appointments	03-04	CI
Sector Update: Health Care Stocks Rising Late Afternoon	03-01	MT
Sector Update: Health Care Stocks Advance Friday Afternoon	03-01	MT
Shattuck Labs Shares Rise as Q4 Net Loss Narrows	03-01	MT
Shattuck Labs, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	02-29	CI
Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights	02-29	GL
Shattuck Labs, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-29	CI
Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights	02-29	AQ
Shattuck Labs Announces Participation in Upcoming March Conferences	02-26	GL
Shattuck Labs Collaborates With Ono Pharmaceutical to Develop Fusion Proteins	02-14	MT
Ono Enters into a Drug Discovery Collaboration and Option Agreement with Shattuck Labs to Generate Bifunctional Fusion Proteins	02-14	PR
Shattuck Strikes Joint Development Deal With Japan's Ono Pharma	02-13	DJ
Shattuck Labs Enters into Strategic Collaboration and License Agreement with Ono Pharmaceutical to Generate Bifunctional Fusion Proteins for the Treatment of Autoimmune and Inflammatory Diseases	02-13	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Shattuck Labs, Inc.

Equities

STTK

US82024L1035

All News

Filters